1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc.

ZBH
Zimmer Biomet Holdings, Inc.US flagNew York Stock Exchange
88.33
USD
-0.24
- -
17.09BMarket Cap

Total Valuation

Zimmer Biomet Holdings, Inc. carries a market capitalization of 17.09B, placing it among publicly traded companies globally. Its enterprise value stands at 24.87B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap17.09B
Enterprise Value24.87B

Share Statistics

Zimmer Biomet Holdings, Inc. currently has 193.40M shares outstanding.

Shares Outstanding193.40M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Zimmer Biomet Holdings, Inc. trades at a trailing price-to-earnings ratio of 23.40. The price-to-sales ratio is 2.12, and the price-to-book ratio stands at 1.51.

PE Ratio23.40
PS Ratio2.12
PB Ratio1.51
P/TBV Ratio-9.91
P/FCF Ratio9.03
P/OCF Ratio10.64

Enterprise Valuation

On an enterprise value basis, Zimmer Biomet Holdings, Inc. trades at an EV/EBITDA multiple of 9.86 and an EV/FCF ratio of 11.16. The EV/Sales ratio of 2.96 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.61 provides insight into valuation relative to core operating earnings.

EV / Sales2.96
EV / EBITDA9.86
EV / EBIT17.61
EV / FCF11.16

Financial Position

Zimmer Biomet Holdings, Inc. maintains a current ratio of 1.73, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 58.91, indicating elevated leverage, while an interest coverage ratio of 8.54 demonstrates adequate ability to service its debt obligations.

Current Ratio1.73
Quick Ratio0.75
Debt / Equity58.91
Debt / EBITDA2.96
Interest Coverage8.54

Financial Efficiency

Zimmer Biomet Holdings, Inc. posts a return on equity of 6.61 and a return on invested capital of 5.99.

Return on Equity (ROE)6.61
Return on Assets (ROA)3.39
Return on Invested Capital (ROIC)5.99
Return on Capital Employed (ROCE)5.36
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.12

Taxes

Over the trailing twelve months, Zimmer Biomet Holdings, Inc. has paid 142.30M in income taxes, reflecting an effective tax rate of 15.76.

Income Tax142.30M
Effective Tax Rate15.76

Stock Price Statistics

Zimmer Biomet Holdings, Inc.'s stock has declined approximately -4.15582% over the past 52 weeks. The 50-day moving average sits at 87.32, while the 200-day moving average is 92.87.

Beta (5Y)N/A
52-Week Price Change-4.15582%
50-Day Moving Average87.32
200-Day Moving Average92.87
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Zimmer Biomet Holdings, Inc. generated 8.41B in revenue and converted that into 761.10M in net income, yielding earnings per share of 3.85. EBITDA reached 2.52B, while operating income came in at 1.41B.

Revenue8.41B
Gross Profit5.89B
Operating Income1.41B
Pretax Income903.10M
Net Income761.10M
EBITDA2.52B
EBIT1.41B
Earnings Per Share (EPS)3.85

Balance Sheet

Zimmer Biomet Holdings, Inc. holds 424.20M in cash and equivalents against 7.47B in total debt, resulting in a net debt position of 7.05B. Total book value stands at 11.81B, with working capital of 2.10B providing operational flexibility.

Cash & Cash Equivalents424.20M
Total Debt7.47B
Net Debt7.05B
Equity (Book Value)11.81B
Book Value Per Share59.93
Working Capital2.10B

Cash Flow

Zimmer Biomet Holdings, Inc. produced 1.67B in operating cash flow over the past twelve months. After subtracting -305.20M in capital expenditures, free cash flow totaled 1.37B - equivalent to 6.95 per share.

Operating Cash Flow1.67B
Capital Expenditures-305.20M
Free Cash Flow1.37B
FCF Per Share6.95

Margins

Zimmer Biomet Holdings, Inc. operates with a gross margin of 70.03, reflecting its pricing power and cost economics. The operating margin of 16.80 and net profit margin of 9.05 provide insight into operational efficiency.

Gross Margin70.03
Operating Margin16.80
Pretax Margin10.74
Profit Margin9.05
EBITDA Margin29.99

Dividends & Yields

The company's payout ratio of 24.91 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.96
Dividend YieldN/A
Payout Ratio24.91
Shareholder Yield3.47
FCF Yield11.07

Stock Splits

Zimmer Biomet Holdings, Inc.'s most recent stock split took place on March 1, 2022 with a 100:103 split ratio.

Last Split Date3/1/2022
Split Ratio100:103

Scores

Zimmer Biomet Holdings, Inc. posts an Altman Z-Score of 4.96, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.96